Prevalence and associated factors of metabolic syndrome among patients with severe mental illness attending Amanuel Mental Specialized Hospital in Addis Ababa, Ethiopia: hospital-based cross-sectional study.

Helena Getenet, Yeweyenhareg Feleke, Ruth Tsigebrhan, Tadesse Lejisa, Genet Ashebir

Abstract read

In one paragraph

Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Helena GetenetDepartment of Internal Medicine, Endocrinology and Metabolism Unit, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia. helenagetenet@gmail.com.

Yeweyenhareg FelekeDepartment of Internal Medicine, Endocrinology and Metabolism Unit, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Ruth TsigebrhanDepartment of Psychiatryand, School of Medicine , WHO Collaborating Center in Mental Health Research and Capacity-Building, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Tadesse LejisaNational Clinical Chemistry Reference Laboratory, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Genet AshebirNational Clinical Chemistry Reference Laboratory, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMetabolic syndrome (MetS) is the leading cause of mortality and morbidity in patients with severe mental illness (SMI). The present study was designed to determine the prevalence and associated factors of MetS among people with SMI attending the Amanuel Mental Specialized Hospital in Addis Ababa, Ethiopia.

methodsA hospital-based cross-sectional study was conducted among people with SMI attending the outpatient psychiatric department. Socio-demographic and other clinical data were collected using a structured questionnaire. A standardized chemistry analyzer measured lipid profiles and blood glucose levels at the Ethiopian Public Health Institute. Univariable and multivariable logistic regression analysis was conducted to examine the association of the outcome with clinical and socio-demographic variables.

resultsA total of 305 participants with SMI were recruited, 79% (n = 241) were male. The overall prevalence of MetS was 28.5% (n = 87), 31.5% (n = 63) among all the participants diagnosed with schizophrenia, and 25% (n = 13) among participants diagnosed with bipolar disorders. The most frequent metabolic abnormality was low high-density lipoprotein (HDL) 88.5% (n = 77). About 54% (n = 47) had abnormal waist circumference; 27.5% (n = 84) of the participants had a blood pressure of ≥ 130/85 mmHg; 4.6% (n = 14) had fasting blood glucose above 100 mg/dl; and 36.4% (n = 111) had triglyceride levels above 150 mg/dl. On multivariable analysis, increasing age (Adjusted odds ratio (aOR) = 1.12, 95% CI 1.08, 1.16) and having secondary education and above (aOR = 2.64, 95% CI 1.24, 5.50) compared to primary education, increasing duration of treatment (aOR = 1.11, 95% CI 1.03, 1.18) and alcohol use (aOR = 1.89, 95% CI 1.03, 3.47) were associated with MetS. 27.2% (n = 83) of the participants with SMI were overweight, and 4.6% (n = 14) had obesity. Increasing age (aOR = 1.11, 95% CI 1.05, 1.14), being female (aOR = 2.42, 95% CI 1.17, 5.01), smoking (aOR = 2.83, 95% CI 1.30, 6.15) and use of second-generation antipsychotics (aOR = 2.64, 95% CI 1.41, 4.94) were significantly associated with being overweight/obesity.

conclusionsIndividuals with SMI receiving care at a tertiary healthcare facility in Ethiopia exhibited a high prevalence of overweight/obesity and MetS. Therefore, health education and early screening for the components of MetS in this vulnerable population are recommended.

Indexed as

Bipolar DisorderMental DisordersMetabolic SyndromeSchizophreniaAdultComorbidityCross-Sectional StudiesEthiopiaFemaleHospitals, PsychiatricHumansMaleMiddle AgedPrevalenceRisk FactorsYoung AdultBipolar disorderMajor depressive disorderMetabolic syndromeSchizophreniaSevere mental illness

Identifiers

PMID40229724

DOI10.1186/s12888-025-06845-w

PMCPMC11995647

What Socratic holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.